- Home
- NUTX vs XERS Comparison
NUTX vs XERS Comparison
Compare NUTX & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUTX
- XERS
- Stock Information
- Founded
- NUTX 2011
- XERS 2005
- Country
- NUTX United States
- XERS United States
- Employees
- NUTX N/A
- XERS N/A
- Industry
- NUTX Retail: Computer Software & Peripheral Equipment
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- NUTX Technology
- XERS Health Care
- Exchange
- NUTX Nasdaq
- XERS Nasdaq
- Market Cap
- NUTX 691.6M
- XERS 752.7M
- IPO Year
- NUTX N/A
- XERS 2018
- Fundamental
- Price
- NUTX $112.80
- XERS $5.44
- Analyst Decision
- NUTX Strong Buy
- XERS Strong Buy
- Analyst Count
- NUTX 2
- XERS 6
- Target Price
- NUTX $262.50
- XERS $6.25
- AVG Volume (30 Days)
- NUTX 266.0K
- XERS 2.2M
- Earning Date
- NUTX 08-07-2025
- XERS 08-07-2025
- Dividend Yield
- NUTX N/A
- XERS N/A
- EPS Growth
- NUTX N/A
- XERS N/A
- EPS
- NUTX 12.01
- XERS N/A
- Revenue
- NUTX $624,284,633.00
- XERS $222,551,000.00
- Revenue This Year
- NUTX $65.82
- XERS $35.03
- Revenue Next Year
- NUTX $4.98
- XERS $18.31
- P/E Ratio
- NUTX $9.64
- XERS N/A
- Revenue Growth
- NUTX 141.25
- XERS 29.88
- 52 Week Low
- NUTX $5.25
- XERS $2.10
- 52 Week High
- NUTX $184.28
- XERS $6.07
- Technical
- Relative Strength Index (RSI)
- NUTX 44.43
- XERS 68.58
- Support Level
- NUTX $108.17
- XERS $4.62
- Resistance Level
- NUTX $140.42
- XERS $5.39
- Average True Range (ATR)
- NUTX 12.37
- XERS 0.23
- MACD
- NUTX 0.12
- XERS 0.08
- Stochastic Oscillator
- NUTX 27.11
- XERS 94.85
About NUTX Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).